APA

Auerswald G., Eberspächer B., Engl W., Güthner C., Koksch M., Kreuz W., Nimtz A., Pindur G., Scheel H., Schreiber J. D., Siekmann J., Turecek P. L. & Wolf H. (20021125). Successful treatment of patients with von Willebrand disease using a high-purity double-virus inactivated factor VIII/von Willebrand factor concentrate (Immunate). : Seminars in thrombosis and hemostasis.

Chicago

Auerswald Günter, Eberspächer Bruno, Engl Werner, Güthner Christiane, Koksch Marie, Kreuz Wolfhart, Nimtz Antje, Pindur Gerhard, Scheel Horst, Schreiber Jörg D, Siekmann Jürgen, Turecek Peter L and Wolf Hans-Heinrich. 20021125. Successful treatment of patients with von Willebrand disease using a high-purity double-virus inactivated factor VIII/von Willebrand factor concentrate (Immunate). : Seminars in thrombosis and hemostasis.

Harvard

Auerswald G., Eberspächer B., Engl W., Güthner C., Koksch M., Kreuz W., Nimtz A., Pindur G., Scheel H., Schreiber J. D., Siekmann J., Turecek P. L. and Wolf H. (20021125). Successful treatment of patients with von Willebrand disease using a high-purity double-virus inactivated factor VIII/von Willebrand factor concentrate (Immunate). : Seminars in thrombosis and hemostasis.

MLA

Auerswald Günter, Eberspächer Bruno, Engl Werner, Güthner Christiane, Koksch Marie, Kreuz Wolfhart, Nimtz Antje, Pindur Gerhard, Scheel Horst, Schreiber Jörg D, Siekmann Jürgen, Turecek Peter L and Wolf Hans-Heinrich. Successful treatment of patients with von Willebrand disease using a high-purity double-virus inactivated factor VIII/von Willebrand factor concentrate (Immunate). : Seminars in thrombosis and hemostasis. 20021125.